# data[].attributes.body
First and only FDA-approved heart failure monitor proven to reduce heart failure hospital admissions and improve quality of life.

Clinically proven to reduce hospital admissions by 33% over an average of 18 months.

# data[].attributes.attachment_link.keywords[]
heart failure (disease or medical condition)

# data[].attributes.attachment_link.title
Cardio Mems For Congestive Heart Failure

# data[].attributes.attachment_link.description
The CardioMems (from St. Jude Medical) device allows doctors to monitor patients with congestive heart failure from the comfort of the patients own home. Medication adjustments and lifestyle changes can be advised often weeks before medical intervention is needed.

# data[].attributes.body
Abraham, W. T., Stevenson, L., Bourge, R. C., Lindenfeld, J., Bauman, J., & Adamson, P. B. (2016). Sustained
efficacy of pulmonary artery pressure to guide to adjustment of chronic heart failure therapy: Complete follow-
up results from the CHAMPION randomized trial. The Lancet, 387(10017), 453-461.
http://dx.doi.org/10.1016/S0140-6736(15)00723-0
Mount Sinai Medical Center. (2015).  Miniature heart sensor keeps heart failure patients out of the hospital.
ScienceDaily. Retrieved October 4, 2017 from www.sciencedaily.com/releases/2015/06/150611114202.htm

# data[].attributes.body
Improved quality of life

Cost effective care for heart failure patients

> 98% cases free of complications

Minimally invasive procedure

No battery

Reduction in hospital admissions

Patient user-friendly

# data[].attributes.body
The system measures and monitors pulmonary artery pressures and heart rate in New York Heart Association Class III heart failure patients who have been hospitalized for heart failure during the previous year.

Opinion
This device could drastically decrease the number of heart failure re-admissions. A reduction in re-admissions is not only a positive for the patient but helps with the financial burden on the hospital for 30 day re-admissions.

# data[].attributes.body
Summary:

Developed by St. Jude Medical and FDA approved in 2014

A small pressure-sensing monitor that is placed directly in the pulmonary artery.  The sensor monitors for an increase in pulmonary artery pressure which is a first sign of worsening heart failure.  This hemodynamic data from the device is sent directly to the physician.  The physician can use this information to make adjustments to medications and treatment plans.

# data[].attributes.body
Limited access due to limited number of facilities that use device

Possible procedural complications (ex. bleeding, infection, hematoma)

Must be able to take 2 types of anticoagulation medications for one month post insertion